Skip to main content
رجوع
Watch Compare

VSEE HEALTH, INC.

جودة البيانات: 100%
مُدرج أيضًا باسم VSEEW Nasdaq
VSEE
Nasdaq Services Health Services
KWD 0.23
▼ KWD 0.01 (-4.17%)
القيمة السوقية: 11.47 M
السعر
KWD 0.24
القيمة السوقية
11.47 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—

Quick Summary

النقاط الرئيسية

Negative free cash flow of -3.48 M
Capital efficient — spends only 0.20% of revenue on capex

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)40.27%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net Margin-100.65%
Op. Margin-65.55%

الأمان

Debt / Equity
N/A
Current Ratio0.16
Interest Coverage-3.41

التقييم

PE (TTM)
-0.78
أعلى من متوسط القطاع (-1.17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Services (502 نظير)
المقياس السهم وسيط القطاع
P/E -0.8 -1.2
P/B — 1.4
ROE % — -15.7
Net Margin % -100.7 -18.3
Rev Growth 5Y % — 3.8
D/E — 0.4

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

لا تتوفر تقديرات مستقبلية

All Fundamental Metrics
Growth
Revenue Growth (1Y) 40.27% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 14.62 M Net Income (TTM) -14.71 M
ROE N/A ROA -79.71%
Gross Margin 50.32% Operating Margin -65.55%
Net Margin -100.65% Free Cash Flow (TTM) -3.48 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.16
Interest Coverage -3.41 Asset Turnover 0.79
Working Capital -19.70 M Tangible Book Value -19.83 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.78 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.78
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -30.31%
Market Cap 11.47 M Enterprise Value 14.43 M
Per Share
EPS (Diluted TTM) -0.73 Revenue / Share 0.31
FCF / Share -0.07 OCF / Share -0.07
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.20% FCF Conversion 23.62%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 14.62 M 10.42 M — —
Net Income -14.71 M -57.70 M -4.41 M -3.24 M
EPS (Diluted) -0.73 -5.65 -1.08 -0.25
Gross Profit 7.36 M 7.18 M — —
Operating Income -9.58 M -62.15 M -2.59 M -3.59 M
EBITDA — — — —
R&D Expenses — — — —
SG&A Expenses — — — —
D&A 2.59 M 1.32 M — —
Interest Expense 2.81 M 211,459.0 — 125,980.0
Income Tax 68,426.0 -1.64 M 187,225.0 187,225.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 22.41 M 19.99 M 1.37 M 7.63 M
Total Liabilities 16.96 M 20.01 M 12.35 M 7.67 M
Shareholders' Equity 5.45 M -18,488.0 -12.27 M -7.43 M
Total Debt 2.74 M 1.93 M — —
Cash & Equivalents 5.27 M 326,115.0 1,863.0 106,998.0
Current Assets 8.37 M 3.02 M 1,863.0 106,998.0
Current Liabilities 16.24 M 19.01 M 7.98 M 3.30 M